Pricing Log in Create free account

Intensity Therapeutics Inc. (INTS) vs Passage Bio, Inc. (PASG)

Intensity Therapeutics Inc. and Passage Bio, Inc. are both Biotechnology companies. Intensity Therapeutics Inc. and Passage Bio, Inc. are of similar size ($11.6M and $11.0M). Across the 10 metrics below, Intensity Therapeutics Inc. leads on 6 and Passage Bio, Inc. on 4.

Valuation

Metric INTS PASG Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.98 2.51 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.03 0.34 0.64
EV/Sales n/m n/m 9.21
Earnings yield (50.85%) (325.29%) (33.15%)
Free cash flow yield (98.74%) (326.67%) (25.50%)

Profitability

Metric INTS PASG Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (195.88%) (169.09%) (56.36%)
Return on assets (139.85%) (69.20%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INTS PASG Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 70.74% 32.94% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INTS PASG Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 5.00 1.22 4.72
Net debt to EBITDA 0.99 0.96 0.96

Dividend

Metric INTS PASG Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric INTS PASG Biotechnology median
Market cap 11.04m 11.59m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack